1. Scrip
  2. >>COVID-19

Sanofi/GSK Working With The US To Increase COVID-19 Vaccine Capacity

 
• By Mary Jo Laffler

The $2.1bn investment under the US’ Operation Warp Speed will fund development, scale-up of US manufacturing and the first 100 million doses. 

Doctor, nurse, scientist hand in blue gloves holding flu, measles, coronavirus, covid-19 vaccine disease preparing for child, baby, adult, man and woman vaccination shot, medicine and drug concept.

A new investment from the US government will help Sanofi and GlaxoSmithKline plc “significantly” increase capacity to produce their COVID-19 vaccine.

The $2.1bn deal signed with the US Department of Health and Human Services and the Department of Defense “will help...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from COVID-19

More from Scrip